Canada markets closed

Connect Biopharma Holdings Limited (CNTB)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.5000+0.0700 (+4.90%)
At close: 04:00PM EDT
1.4500 -0.05 (-3.33%)
After hours: 04:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 82.65M
Enterprise Value -35.53M
Trailing P/E N/A
Forward P/E 0.92
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.82
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.19

Trading Information

Stock Price History

Beta (5Y Monthly) -0.49
52-Week Change 320.97%
S&P500 52-Week Change 326.27%
52 Week High 32.8400
52 Week Low 30.5350
50-Day Moving Average 31.5000
200-Day Moving Average 31.1831

Share Statistics

Avg Vol (3 month) 3160.61k
Avg Vol (10 day) 365.62k
Shares Outstanding 555.1M
Implied Shares Outstanding 655.87M
Float 816.05M
% Held by Insiders 141.27%
% Held by Institutions 144.06%
Shares Short (Apr 30, 2024) 431.23k
Short Ratio (Apr 30, 2024) 40.18
Short % of Float (Apr 30, 2024) 40.10%
Short % of Shares Outstanding (Apr 30, 2024) 40.06%
Shares Short (prior month Mar 28, 2024) 4115.47k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.07%
Return on Equity (ttm)-46.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -64.23M
Net Income Avi to Common (ttm)-59.5M
Diluted EPS (ttm)-1.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)118.7M
Total Cash Per Share (mrq)2.15
Total Debt (mrq)465k
Total Debt/Equity (mrq)0.46%
Current Ratio (mrq)4.99
Book Value Per Share (mrq)1.83

Cash Flow Statement

Operating Cash Flow (ttm)-47.93M
Levered Free Cash Flow (ttm)-27.07M